Clinical, pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer: A multicenter experience in Madrid (original) (raw)

Journal of Clinical Oncology, 2018

Abstract

e21128Background: Long survivors (LS) in non-small-cell lung cancer (NSCLC), defined as an overall survival (OS) greater than 2 years, are less than 10% in most series. Classical prognosis factors ...

Amparo Benito hasn't uploaded this paper.

Let Amparo know you want this paper to be uploaded.

Ask for this paper to be uploaded.